Table 1. Baseline demographic and clinical characteristics of study participants.
| Characteristic | ASSIP Group (n = 60) | Control Group (n = 60) | All Participants (n = 120) | p-Value |
|---|---|---|---|---|
| Number of women/men | 36/24 | 30/30 | 120 | 0.36 a |
| Age (years), mean (SD) | 36.5 (14.3) | 39.2 (14.6) | 37.8 (14.4) | 0.32 b |
| Time to first interview (days), median (IQR) | 16.5 (9.0–33.5) | 17.5 (9.0–34.5) | 17 (9.0–34.3) | 0.78 c |
| Diagnosis d (ICD-10), n (percent) | 0.10 a | |||
| F1* | 10 (17%) | 20 (33%) | 30 (25%) | |
| F3* | 40 (67%) | 36 (60%) | 76 (63%) | |
| F4* | 25 (42%) | 28 (47%) | 53 (44%) | |
| F6* | 8 (13%) | 12 (20%) | 20 (17%) | |
| Other | 6 (10%) | 1 (2%) | 7 (6%) | |
| BDI sum score, mean (SD) | 18.1 (11.4) | 18.3 (12.2) | 18.2 (11.8) | 0.90 b |
| Participants on psychotropic drugs, n (percent) | 38 (63%) | 32 (53%) | 70 (58%) | 0.65 a |
| Psychotropic drugs used, n (percent) | ||||
| Antidepressants | 32 (53%) | 24 (40%) | 56 (47%) | |
| Antipsychotics | 10 (17%) | 11 (18%) | 21 (18%) | |
| Tranquilizers | 6 (10%) | 9 (15%) | 15 (13%) | |
| Others | 7 (12%) | 6 (10%) | 13 (11%) | |
| Married, n (percent) | 19 (32%) | 15 (25%) | 34 (28%) | 0.54 a |
| Children, n (percent) | 25 (42%) | 19 (32%) | 44 (37%) | 0.34 a |
| Employed, n (percent) | 34 (57%) | 36 (60%) | 70 (58%) | 0.85 a |
| Prior suicide attempts, n (percent) | 0.071 a | |||
| 0 | 34 (56%) | 26 (43%) | 60 (50%) | |
| 1 | 16 (27%) | 13 (22%) | 29 (24%) | |
| 2 or more (multiple) | 10 (17%) | 21 (35%) | 31 (26%) | |
| Lifetime inpatient days, median (IQR) | 21 (0–90) | 21 (0–90) | 21 (0–90) | 0.68 c |
| Outpatient sessions in last 6 months, median (IQR) | 8 (2.25–15.75) | 2.5 (0–10.5) | 4.5 (0–13.75) | 0.010 c |
aχ2 test.
b t-test.
cMann-Whitney U test.
dTotals exceed 100% because participants had multiple diagnoses. International Classification of Diseases (ICD-10) codes: F1*, substance abuse disorder; F3*, affective disorder; F4*, neurotic and acute stress reaction; F6*, personality disorder.
IQR, interquartile range.